No Data
Cai Na Co., Ltd. (301122.SZ): Net income for the year 2024 is expected to decrease by 44.92%-57.36%.
Gelonghui, January 22丨Caina Co., Ltd. (301122.SZ) announced its 2024 annual performance forecast, with a net income attributable to shareholders of the listed company expected to be between 48 million yuan and 62 million yuan, a decrease of 44.92%-57.36% compared to the same period last year; the net income after deducting non-recurring gains and losses is expected to be between 28 million yuan and 40 million yuan, a decrease of 52.86%-67.00% compared to the same period last year. During the reporting period, affected by the import warning from the USA Food and Drug Administration (hereinafter referred to as "the USA FDA"), some of the company's medical syringe products are temporarily unable to.
Adopted shares: 2024 annual results forecast
Mongolia Jinyuan (02585.HK) recommends adopting a stock incentive plan and suggests revising the "Articles of Association".
On January 14, Gelonghui reported that Mengjinyuan (02585.HK) announced that the Board of Directors approved during the 15th meeting of the second Board of Directors held on January 14, 2025, (1) the proposal to adopt the company's Listed in Hong Kong stock incentive plan; and (2) the proposal to amend the company's articles of association. The stock incentive plan aims to: (a) provide opportunities to hold company equity to attract, motivate, and retain skilled and experienced personnel to work towards the future development and expansion of the company and its subsidiaries; (b) improve the company's incentive mechanism to attract, motivate, and retain core employees who make significant contributions to the company's sustained operation, development, and long-term growth.
SUNSHINE PAPER (02002) has adopted a share incentive plan.
SUNSHINE PAPER (02002) announced that on January 6, 2025, the Board of Directors has adopted the share incentive plan. The plan...
Cana Shares (301122.SZ): Wholly-owned subsidiary has obtained a patent certificate.
On January 3, Glonghui reported that Changna Shares (301122.SZ) announced that its wholly-owned subsidiary Anna Medical (Jiangsu) Co., Ltd. (referred to as "Anna Medical") recently received a patent certificate issued by the National Intellectual Property Administration for a needle cap feeding mechanism.
WESTCHINACEMENT (02233) issued 3.4 million shares due to the adoption of the stock Options plan.
WESTCHINACEMENT (02233) announced that eligible employees according to the company's stock plan adopted on March 31, 2010...
Caina Technology's (SZSE:301122) Returns On Capital Not Reflecting Well On The Business
